BIOC fundamentals
GLAXO SMITH KLINE financial statements, including revenue, expenses, profit, and loss
The total revenue of BIOC for the last quarter is 713.81 M EGP, and it's 23.83% higher compared to the previous quarter. The net income of Q1 24 is -8.99 M EGP.
Q1 '14
Q2 '14
Q3 '14
Q4 '14
Q1 '15
Q2 '15
Q3 '15
Q4 '15
Q1 '16
Q2 '16
Q3 '16
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q1 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EGP
Q1 '14
Q2 '14
Q3 '14
Q4 '14
Q1 '15
Q2 '15
Q3 '15
Q4 '15
Q1 '16
Q2 '16
Q3 '16
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q1 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
TTM